SARITA PRAJAPATI

Allopathic & Osteopathic Physicians|Family Medicine WEST LAKE HILLS, TX NPI 1346337490

General Payments — all program years on this page

$3,089.28

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 158
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $560.47 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $560.4722

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $323.2015
2019 $398.5319
2020 $248.7416
2021 $527.7233
2022 $369.9418
2023 $660.6835
2024 $560.4722

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096968246 Novo Nordisk Inc $14.50 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097440038 Novo Nordisk Inc $23.36 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097675456 Novo Nordisk Inc $29.26 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105306426 ABBVIE INC. $24.17 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116062243 GlaxoSmithKline, LLC. $14.19 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116365345 GlaxoSmithKline, LLC. $15.36 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116568419 GlaxoSmithKline, LLC. $15.44 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116677861 GlaxoSmithKline, LLC. $17.06 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116724738 GlaxoSmithKline, LLC. $15.21 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117658742 Amgen Inc. $20.03 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118963351 Otsuka America Pharmaceutical, Inc. $14.10 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132013238 PFIZER INC. $18.97 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135378544 Lilly USA, LLC $14.19 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135396495 Lilly USA, LLC $21.97 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135416077 Lilly USA, LLC $19.72 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145957616 Lundbeck LLC $17.38 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148319182 Axsome Therapeutics, Inc. $23.98 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148319184 Axsome Therapeutics, Inc. $18.06 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148319186 Axsome Therapeutics, Inc. $13.53 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151514585 Teva Pharmaceuticals USA, Inc. $18.84 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152978215 ShockWave Medical, Inc $168.33 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153334573 Dexcom, Inc. $22.82 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.